Pharmalot Ed Silverman Pharmalot, Pharmalittle: Shkreli talk at Harvard elicits a fire alarm and jeers
Pharmalot Ed Silverman Drug maker pays $100 million antitrust fine thanks, in part, to Martin Shkreli
Pharmalot Ed Silverman Pharmalot, Pharmalittle: Patient advocacy groups are failing their members in the drug pricing debate
Pharmalot Ed Silverman Pharmalot, Pharmalittle: Docs disciplined for misconduct still paid by pharma to be speakers, advisers
Biotech Meghana Keshavan How global warming could help Martin Shkreli’s old company stay out of bankruptcy
Pharmalot Ed Silverman Pharmalot, Pharmalittle: Martin Shkreli may face more securities fraud charges
Business Damian Garde Biotech bankruptcies, a trip to the Vatican, and Adam Feuerstein’s favorite bar
Politics Dylan Scott Drug sales dropped precipitously after Shkreli’s Turing hiked price, senator says
Pharmalot Ed Silverman Pharmalot, Pharmalittle: Walgreens threatens to terminate Theranos partnership
Pharmalot Ed Silverman Pharmalot, Pharmalittle: Amgen releases ‘secret’ data, AstraZeneca forecasts dip in profits